RFK expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 8.018400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
5.740600E-01
Normal-vs-Stage2
7.283000E-01
Normal-vs-Stage3
3.453000E-01
Normal-vs-Stage4
7.012800E-01
Stage1-vs-Stage2
1.117210E-01
Stage1-vs-Stage3
4.312100E-02
Stage1-vs-Stage4
8.843600E-01
Stage2-vs-Stage3
2.270800E-01
Stage2-vs-Stage4
2.598600E-01
Stage3-vs-Stage4
8.388500E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
7.453200E-01
Normal-vs-AfricanAmerican
6.037000E-01
Normal-vs-Asian
8.630200E-01
Caucasian-vs-AfricanAmerican
6.560300E-02
Caucasian-vs-Asian
8.418800E-01
AfricanAmerican-vs-Asian
2.719800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
9.036600E-01
Normal-vs-Female
6.971800E-01
Male-vs-Female
3.125600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
9.682400E-01
Normal-vs-Age(41-60Yrs)
8.537000E-01
Normal-vs-Age(61-80Yrs)
6.641400E-01
Normal-vs-Age(81-100Yrs)
4.970000E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
3.439200E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
9.747900E-02
Age(21-40Yrs)-vs-Age(81-100Yrs)
4.196600E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
2.748500E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
1.235000E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
6.740000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
5.327400E-01
Normal-vs-Daily Drinker
6.804800E-01
Normal-vs-Weekly Drinker
5.229600E-01
Normal-vs-Occasional Drinker
9.076600E-01
Normal-vs-Social Drinker
9.460800E-01
Non Drinker-vs-Daily Drinker
9.170000E-01
Non Drinker-vs-Weekly Drinker
8.079800E-01
Non Drinker-vs-Occasional Drinker
3.239400E-01
Non Drinker-vs-Social Drinker
2.230200E-01
Daily Drinker-vs-Weekly Drinker
7.935200E-01
Daily Drinker-vs-Occasional Drinker
5.013400E-01
Daily Drinker-vs-Social Drinker
3.776400E-01
Weekly Drinker-vs-Occasional Drinker
3.239400E-01
Weekly Drinker-vs-Social Drinker
2.711600E-01
Occasional Drinker-vs-Social Drinker
7.391200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
6.416000E-02
Normal-vs-Grade 2
2.343600E-02
Normal-vs-Grade 3
5.812300E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
2.018200E-01
Grade 1-vs-Grade 3
4.911500E-02
Grade 1-vs-Grade 4
6.416000E-02
Grade 2-vs-Grade 3
1.819380E-01
Grade 2-vs-Grade 4
2.343600E-02
Grade 3-vs-Grade 4
5.812300E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
4.378000E-01
Normal-vs-NonDiabetic
8.030000E-01
Diabetic-vs-NonDiabetic
1.024990E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
4.434800E-01
Normal-vs-NoPancreatitis
7.424200E-01
Pancreatitis-vs-NoPancreatitis
1.683780E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
8.521000E-01
Normal-vs-N1
7.749000E-01
N0-vs-N1
7.970200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
9.763800E-01
Normal-vs-TP53-NonMutant
8.026400E-01
TP53-Mutant-vs-TP53-NonMutant
3.362200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
